Vitrivax Bio

VitriVax develops a thermostable, single-injection vaccine platform (ALTA) to eliminate cold chain needs and allow timed release up to 6 months.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2025
Vitrivax Hover Image